References
- Otvos L Jr, Wade JD. Current challenges in peptide-based drug discovery. Front Chem. 2014;2:62. doi: 10.3389/fchem.2014.00062
- Otvos L Jr, Wade JD. Big peptide drugs in a small molecule world. Front Chem. 2023;11:1302169. doi: 10.3389/fchem.2023.1302169
- Hruby V. Designing peptide receptor agonists and antagonists. Nat Rev Drug Discov. 2002;1(11):847–858. doi: 10.1038/nrd939
- Pandey S, Mangmool S, Parichatikanond W. Multifaceted roles of GLP-1 and its analogs: a review on molecular mechanisms with a cardiotherapeutic perspective. Pharmaceuticals. 2023;16(6):836. doi: 10.3390/ph16060836
- Hauser AS, Attwood MM, Rask-Andersen M, et al. Trends in GPCR drug discovery: new agents, targets and indications. Nat Rev Drug Discov. 2017;16(12):829–842. doi: 10.1038/nrd.2017.178
- Bellissimo CA, Gandhi S, Castellani LN, et al. The slow-release adiponectin analog ALY688-SR modifies early-stage disease development in the D2.Mdx mouse model of Duchenne muscular dystrophy. Am J Physiol Cell Physiol. 2024;326:C1011–C1026. doi: 10.1152/ajpcell.00638.2023
- Lau J, Bloch P, Schäffer L, et al. Discovery of the once-weekly glucagon-like peptide-1 (GLP-1) analogue Semaglutide. J Med Chem. 2015;58(18):7370–7380. doi: 10.1021/acs.jmedchem.5b00726
- Otvos LJ, Haspinger E, La RF, et al. Design and development of a peptide-based adiponectin receptor agonist for cancer treatment. BMC Biotechnol. 2011;11:90. doi: 10.1186/1472-6750-11-90
- Klusty T, Weinmeyer R. Supreme court to myriad genetics: Synthetic DNA is patentable but isolated genes are not. AMA J Ethics. 2015;17:849–853. doi: 10.1001/journalofethics.2015.17.9.hlaw1-1509
- Bluhm ME, Schneider VA, Schäfer I, et al. N-Terminal Ile-Orn- and Trp-Orn-motif repeats enhance membrane interaction and increase the antimicrobial activity of Apidaecins against Pseudomonas aeruginosa. Front Cell Dev Biol. 2016;4:39. doi: 10.3389/fcell.2016.00039
- Hansen S, Nile AH, Mehta SC, et al. Lead optimization yields high affinity frizzled 7-targeting peptides that modulate clostridium difficile Toxin B pathogenicity in epithelial cells. J Med Chem. 2019;62:7739–7750. doi: 10.1021/acs.jmedchem.9b00500
- Sun Y, Zang Z, Zhong L, et al. Identification of adiponectin receptor agonist utilizing a fluorescence polarization based high throughput assay. PLOS ONE. 2013;8(5):e63354. doi: 10.1371/journal.pone.0063354
- Ferrazzano F, Catani M, Cavazzini A, et al. Sustainability in peptide chemistry: current synthesis and purification technologies and future challenges. Green Chem. 2022;24(3):975–1020. doi: 10.1039/D1GC04387K
- Reise M, Kranz S, Heyder M, et al. Effectiveness of casein phosphopeptide-amorphous calcium phosphate (CPP-ACP) compared to fluoride products in an in-vitro demineralization model. Materials. 2021;14:5974. doi: 10.3390/ma14205974
- Ngoc LTN, Moon J-Y, Lee Y-C. Insights into bioactive peptides in cosmetics. Cosmetics. 2023;10(4):111. doi: 10.3390/cosmetics10040111